Owings Mills, Maryland Clinical Trials

A listing of Owings Mills, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 82 clinical trials
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Sinusitis With or Without the Presence of Nasal Polyps

This is a 24-week randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the efficacy and safety of intranasal administration of 186 and 372 g twice daily (BID) of OPN-375 in subjects with chronic sinusitis (CS) with or without nasal polyps.

asthma
ct scan
nasal congestion
edema
anosmia
Ear, Nose and Throat Associates at Greater Baltimore Medical Center
 (9.3 away) Contact site
  • 338 views
  • 16 Jul, 2021
  • +98 other locations
S0820 Adenoma and Second Primary Prevention Trial

The investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing a three-year event rate of adenomas and second primary colorectal cancers in patients previously treated for Stages 0 through III colon or rectal cancer.

aspirin
adenoma
rectal carcinoma
anticoagulants
unstable angina
Kaiser Permanente-Woodlawn Medical Center
 (6.5 away) Contact site
  • 2518 views
  • 03 Mar, 2021
  • +1033 other locations
Phase 3 Study of ProstAtak Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer

The purpose of this study is to evaluate the effectiveness of ProstAtak immunotherapy in combination with radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a cancer vaccine effect. Killing tumor cells in an immune stimulatory environment induces the body's immune system to …

tumor cells
external beam radiation therapy
androgens
cancer vaccine
antiandrogen therapy
Chesapeake Urology Research Associates
 (9.3 away) Contact site
  • 1420 views
  • 02 Aug, 2021
  • +78 other locations
Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

The primary objective of Part 1 of the study is to determine if BIIB093 improves functional outcome at Day 90 as measured by the modified Rankin Scale (mRS) when compared with placebo in participants with Large Hemispheric Infarction (LHI). The secondary objectives of Part 1 of the study are to …

glibenclamide
ischemic stroke
thrombectomy
glyburide
MRI
Research Site
 (7.7 away) Contact site
  • 213 views
  • 31 Jul, 2021
  • +221 other locations
Study of Durvalumab + Tremelimumab Durvalumab and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as Consolidation Treatment for Patients with LS-SCLC Who Have Not Progressed Following Concurrent Chemoradiation Therapy

limited stage small cell lung cancer
cancer chemotherapy
chemoradiotherapy
prophylactic cranial irradiation
etoposide
Research Site
 (9.3 away) Contact site
  • 268 views
  • 01 Aug, 2021
  • +246 other locations
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

The purpose of this study is to evaluate the safety and efficacy of Mirikizumab in participants with moderately to severely active ulcerative colitis (UC) who have had an inadequate response to, loss of response, or intolerant to conventional or biologic therapy for UC.

mirikizumab
Woodholme Gastroenterology Associates PA
 (4.3 away) Contact site
  • 1722 views
  • 24 Jul, 2021
  • +880 other locations
Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)

The objectives of this study are to assess the efficacy, safety, and tolerability of PLX-PAD intramuscular administration for the treatment of muscle injury following arthroplasty for HF.

fracture of femur
hip arthroplasty
femoral neck fracture
Sinai Hospital - Rubin Institute for Advanced Orthopedics (RIAO) - Center for Joint Preservation and Replacement,Baltimore,2401 W Belvedere Ave Fl 5
 (7.8 away) Contact site
  • 3 views
  • 01 Jul, 2021
  • +22 other locations
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or IIA Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)

The purpose of this study is to assess the efficacy and safety of stereotactic body radiotherapy (SBRT) plus pembrolizumab (MK-3475) in the treatment of adult participants with unresected stage I or IIA non-small cell lung cancer (NSCLC). The primary study hypotheses are: SBRT plus pembrolizumab prolongs Event-free Survival (EFS) compared …

pembrolizumab
mk-3475
stereotactic body radiation therapy
lung carcinoma
Sinai Hospital of Baltimore ( Site 3011)
 (7.8 away) Contact site
  • 121 views
  • 01 Aug, 2021
  • +178 other locations
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

This phase III trial compares immunotherapy drugs (nivolumab or brentuximab vedotin) when given with combination chemotherapy in treating patients with newly diagnosed stage III or IV classic Hodgkin lymphoma. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the …

measurable disease
corticosteroids
human immunodeficiency virus
monoclonal antibodies
hepatitis
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 68 views
  • 01 Aug, 2021
  • +507 other locations
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

A global, randomized phase III study to evaluate perioperative pembrolizumab with radical cystectomy + pelvic lymph node dissection (RC+PLND) versus RC+PLND alone in cisplatin-ineligible patients with muscle-invasive bladder cancer (MIBC).

Greater Baltimore Medical Center ( Site 0014)
 (9.3 away) Contact site
  • 95 views
  • 02 Aug, 2021
  • +198 other locations